Outpatient Antibiotic Use in Europe and Association with Resistance.

1
Outpatient Antibiotic Use in Europe and
Association with Resistance.
The LANCET Volume 365, Number 9459 12
February 2005
Herman Goossens, M.D., Ph.D., Matus Ferech,
Pharm.D., Robert Vander Stichele, M.D., ,
Monique Elseviers, Ph.D, and the ESAC Project
Group. From the ESAC Management Team, Department
of Microbiology, University of Antwerp,
Universiteitsplein 1, B-2610 Antwerp, Belgium

• Address for correspondence
• Prof. Dr. H. Goossens
• Department of Microbiology, University of
  Antwerp, Universiteitsplein 1, B-2610 Antwerp,
  Belgium
• Tel () 32 3 821 3789
• Fax () 32 3 825 4281
• E-mail Herman.Goossens_at_uza.be

2
Figure 1 Total Outpatient antibiotic use in 26
European countries in 2002
3
Figure 2 Seasonal variation of total outpatient
antibiotic use in 10 European countries
4
Figure 3 Outpatient use of penicillins (J01C) in
26 European countries in 2002
in descending order of narrow spectrum penicillins
5
Figure 5 Outpatient use of the third generation
Cephalosporins in 2002
6
Figure 6 Outpatient use of Macrolides,
Lincosamides and Streptogramins (J01F) in 26
European countries in 2002
7
Figure 7 Outpatient use of Quinolones (J01M) in
26 European countries in 2002